Vimarsana
Biggest News Aggregation in the World

Page 2 - Tb Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tb Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tb Consortium Today - Breaking & Trending Today

Africa falls short of global targets in cutting TB cases and deaths - Vimarsana News

Africa falls short of global targets in cutting TB cases and deaths

Tuberculosis deaths in Africa fell by 26 percent between 2015 and 2021, with high-burden TB countries surpassing initial targets to lower TB cases.

Nigeria, other 6 countries to benefit from 250,000 doses of short course TB treatment - Vimarsana News

Nigeria, other 6 countries to benefit from 250,000 doses of short course TB treatment

Sade Oguntola Nigeria and six other countries are to benefit from a 250,000 patient courses of short course rifapentine-based preventive treatment

Seizing opportunities to end TB: a call for ambition and optimism on World TB Day - Vimarsana News

Seizing opportunities to end TB: a call for ambition and optimism on World TB Day

March 24 marks World Tuberculosis (TB) Day. It is important to reflect on the progress we have made in the fight against TB and the opportunities that lie ahead. Over the past few years, breakthroughs in research and development mean that treatment of drug-resistant TB has been shortened from 20 months to 6 months,1 and a pipeline of new treatment options means that some forms of drug-susceptible TB might be treatable with as little as 2 months of therapy.2 Additionally, affordable and accurate molecular diagnostics promise to revolutionise how we detect TB.

250,000 patients to benefit from free access to short-course TB preventive treatment across seven countries - Vimarsana News

250,000 patients to benefit from free access to short-course TB preventive treatment across seven countries

The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced today that it will provide 250,000 patient courses of short course rifapentine-based preventive treatment regimens to seven countries to help prevent tuberculosis (TB). The patient courses will include the three-month 3HP regimen, and the even shorter 1HP, that is only…